The global bladder scanners market size was valued at USD 177.3 million in 2025 and is projected to grow from USD 187.89 million in 2026 to USD 298.91 million by 2034 at a CAGR of 5.97% during the forecast period 2026-2034.
Bladder scanners are non-invasive ultrasound devices used to measure bladder volume and detect urinary retention or post-void residual urine. They assist healthcare professionals in diagnosing urinary disorders, monitoring bladder function, and reducing the need for catheterization. These scanners improve patient safety, minimize infection risks, and support efficient bedside assessment in hospitals, clinics, and long-term care settings.
The bladder scanners market demand is driven by the rising prevalence of urological disorders, increasing geriatric population, and growing incidence of urinary incontinence and bladder dysfunction. Expanding adoption of non-invasive diagnostic technologies, increasing focus on reducing catheter-associated infections, and advancements in portable ultrasound imaging systems are supporting market growth across hospitals, rehabilitation centers, nursing homes, and ambulatory care facilities globally.
Artificial intelligence is transforming the bladder scanners market by improving diagnostic accuracy, workflow efficiency, and real-time bladder volume assessment in urology and critical care settings. AI-enabled ultrasound imaging, automated bladder recognition, and predictive analytics help healthcare professionals enhance urinary retention detection, reduce catheter-associated complications, and support faster bedside decision-making. Integration of machine learning with portable imaging technologies is accelerating adoption across hospitals, rehabilitation centers, and long-term care facilities globally. The following companies are leveraging AI in bladder scanner technologies:
Development of Ai-enabled 3d Portable Bladder Scanners
AI-enabled 3D bladder scanners are emerging as advanced diagnostic systems capable of delivering automated bladder volume measurement and real-time anatomical visualization in emergency and postoperative care settings. These portable devices utilize machine learning algorithms to improve scan accuracy, reduce operator dependency, and support rapid urinary retention assessment. In 2025, GE HealthCare introduced AI-based Auto Bladder Volume technology within handheld ultrasound platforms for bedside monitoring applications. Growing demand for faster non-invasive diagnostics is accelerating adoption of intelligent portable bladder imaging systems globally.
Integration of Wireless Cloud-connected Bladder Monitoring Platforms in Long-term Care
Wireless bladder scanner platforms integrated with cloud-based patient monitoring systems are emerging as next-generation solutions for elderly care and rehabilitation facilities. These systems enable remote bladder assessment, automated documentation, and predictive urinary monitoring to reduce catheter-associated complications. Healthcare facilities implementing standardized bladder scanning protocols reported nearly 45% lower catheterization rates during urinary retention management programs. Rising emphasis on infection prevention, nursing workflow optimization, and digital patient monitoring is driving strong investment in connected bladder scanner technologies across hospitals and long-term care environments globally.
Bladder Scanners Market Investment and Funding Analysis
The bladder scanners market is witnessing increasing investment and funding activity driven by rising demand for portable ultrasound diagnostics, AI-enabled bladder assessment technologies, and non-invasive urinary monitoring solutions. Investments are primarily focused on development of handheld bladder scanners, integration of artificial intelligence with point-of-care ultrasound systems, and expansion of wireless bladder monitoring platforms for hospitals, rehabilitation centers, and long-term care facilities globally. Following are some major funding and investment activities undertaken by companies in 2025 and 2026:
Key Investment and Funding Activities in Bladder Scanners Market, 2025–2026
Urologic Health
Seed Financing
May 2026
Urologic Health accelerate development and commercialization of its non-invasive bladder function monitoring platform and support FDA 510(k) activities.
USD 11 Million
MAUI Imaging
Series D Funding
July 2025
MAUI Imaging raised Series D funding to accelerate development of advanced ultrasound imaging systems capable of improving portable diagnostic applications including bladder and trauma imaging technologies.
USD 14 Million
EchoNous
Strategic Investment Expansion
September 2025
EchoNous expanded investment toward AI-powered handheld ultrasound and bladder scanning solutions to strengthen point-of-care imaging capabilities for emergency and urology applications.
Undisclosed
Download Free Sample Report to Get Detailed Insights.
Rising Prevalence of Urinary Retention Disorders and Expansion of Catheter-associated Infection Prevention Programs Drives Market
The increasing prevalence of urinary retention, benign prostatic hyperplasia, neurogenic bladder disorders, and postoperative urinary complications is significantly driving demand for bladder scanners across hospitals and surgical recovery units. These devices help clinicians perform rapid non-invasive bladder assessment while minimizing catheterization-associated infections and patient discomfort. Bladder scanners demonstrated diagnostic accuracy comparable to catheterization for post-void residual measurement. Growing aging populations and increasing urological surgical volumes continue to strengthen demand for portable bladder imaging technologies globally.
Growing implementation of hospital infection prevention programs targeting catheter-associated urinary tract infections is significantly accelerating adoption of bladder scanners worldwide. Healthcare providers increasingly utilize portable ultrasound scanners to reduce unnecessary catheterization procedures and improve patient safety outcomes. Studies evaluating bladder scan-guided urinary management protocols reported catheterization reductions exceeding 65% in postoperative care environments. Increasing regulatory focus on hospital-acquired infection reduction and value-based patient care is strengthening demand for accurate bedside bladder monitoring solutions across acute and long-term healthcare settings globally.
High Procurement Costs of Advanced Scanners and Interference from Adjacent Fluid-filled Structures Restrain Market
High procurement costs associated with advanced 3D bladder scanners remain a major restraint for market growth, particularly across small hospitals and emerging healthcare systems. Premium portable ultrasound systems require substantial investment in imaging software, staff training, and maintenance infrastructure. For example, the Verathon BladderScan Prime Plus portable scanner is commercially priced around USD 5,999, while several advanced systems exceed USD 10,000 depending on AI and imaging capabilities. Inconsistent reimbursement policies for non-invasive bladder assessment procedures further reduce purchasing incentives for healthcare providers globally.
Difficulty in distinguishing bladder volume from adjacent fluid-filled anatomical structures acts as a niche clinical restraint in the bladder scanners market. Conditions such as ovarian cysts, ascites, renal cysts, uterine fibroids, and postoperative pelvic fluid accumulation can interfere with ultrasound interpretation and generate inaccurate bladder measurements. Automated scanning algorithms may incorrectly identify surrounding fluid collections as urinary retention, particularly in female and elderly patients. These diagnostic limitations increase risks of unnecessary catheterization and reduce physician confidence in bladder scanner reliability during complex abdominal assessments globally.
Expansion of Home-based Chronic Urinary Care and Increasing Utilization of Bladder Scanners in Pediatric Urology Offer Growth Opportunities for Market Players
The growing shift toward home-based management of chronic urinary disorders is creating specialized opportunities for portable bladder scanners in remote patient monitoring applications. Patients with neurogenic bladder, multiple sclerosis, spinal cord injuries, and long-term urinary dysfunction increasingly require frequent bladder volume assessment outside hospitals. Portable wireless scanners enable caregivers to monitor urinary retention while reducing emergency admissions and catheter dependency. Rising healthcare investment toward decentralized care delivery and aging-in-place programs is accelerating demand for compact home-compatible bladder monitoring technologies globally.
Rising focus on non-invasive pediatric urinary diagnostics is creating significant opportunities for bladder scanner manufacturers across children’s hospitals and neonatal intensive care units. Pediatric patients are highly vulnerable to catheter-associated trauma and infection risks, increasing clinical preference for ultrasound-based bladder monitoring technologies. The growing expansion of pediatric urology services and neonatal critical care infrastructure is strengthening future demand for child-specific portable bladder imaging systems globally.
Integration Difficulties with Hospital Information Systems and Device Performance Issues Challenges Bladder Scanners Market Growth
Integration of bladder scanners with hospital electronic medical records and centralized clinical workflow systems remains a significant operational challenge for healthcare providers. Many portable bladder scanner platforms lack standardized interoperability features required for seamless data transfer, automated documentation, and real-time patient monitoring integration. This increases administrative workload for nursing staff and limits workflow efficiency during high patient-volume situations. In large hospital networks, inconsistent software compatibility and cybersecurity concerns continue to delay adoption of connected bladder monitoring ecosystems globally.
Battery performance limitations and portability constraints in handheld bladder scanners create challenges during continuous point-of-care monitoring applications. Frequent charging requirements, reduced wireless connectivity stability, and limited scan durations can interrupt clinical workflows in emergency rooms, rehabilitation units, and home healthcare environments. Portable systems operating in high-volume hospital settings may also experience durability concerns and calibration inconsistencies over extended usage periods. These operational limitations reduce efficiency and affect clinician preference for advanced portable bladder imaging technologies in demanding healthcare environments globally.
By product type, the 2D ultrasound bladder scanners segment is expected to grow at a CAGR of 6.94% during the forecast period. This growth is driven by rising adoption in nursing homes and rehabilitation facilities due to lower procurement costs, faster bedside urinary assessment, and simplified operator training requirements. Their strong suitability for routine postoperative monitoring, emergency urinary retention screening, and basic point-of-care bladder volume further support market growth.
The 3D ultrasound bladder scanners segment is expected to grow at a CAGR of 7.14% during the forecast period, driven by increasing demand for automated bladder localization and higher imaging precision in obese and complex anatomy patients. Growing preference for catheter reduction protocols and advanced surgical recovery monitoring further sustains product demand.
In 2025, cart-based scanners accounted for a share of 63.70% in the bladder scanners market, by portability. This growth is supported by imaging stability, larger display interfaces, and integration with hospital electronic workflow systems. Their widespread utilization in high-volume surgical wards, intensive care units, and urology departments supports continuous bladder monitoring and complex postoperative urinary assessment procedures globally.
The handheld scanners segment is projected to grow at a CAGR of 7.46% during the forecast period due to increasing adoption in ambulatory care, home healthcare, and emergency bedside diagnostics. Rising demand for wireless portability, rapid urinary retention screening, and AI-assisted point-of-care imaging technologies is accelerating utilization across decentralized healthcare environments globally.
Urology accounted for the largest application segment share of 43.69% revenue share in 2025 due to the increasing prevalence of urinary retention disorders, benign prostatic hyperplasia, and neurogenic bladder conditions. High utilization of bladder scanners for post-void residual volume assessment during routine urological diagnostics and postoperative urinary monitoring procedures globally.
The obstetrics & gynecology segment is expected to grow at a CAGR of 7.56% during the forecast timeframe. This growth is driven by rising postoperative bladder monitoring following cesarean deliveries and increasing urinary dysfunction cases among women. The growing adoption of non-invasive bladder assessment technologies during pelvic floor rehabilitation and gynecological surgical recovery procedures.
Hospitals & clinics accounted for the largest end-use segment with a share of 63.52% in 2025 due to patient admissions requiring postoperative urinary monitoring, widespread implementation of catheter reduction protocols, and availability of advanced ultrasound infrastructure. Increasing utilization of bladder scanners in surgical wards, emergency departments, and intensive care environments further supported segment dominance globally.
The ambulatory surgical centers segment is expected to have the fastest growth in the end-use segment, registering a CAGR of 7.95% during the forecast period. This growth is driven by rising same-day surgical procedures and increasing preference for rapid postoperative urinary assessment. Growing adoption of portable handheld bladder scanners supports faster patient discharge and minimally invasive outpatient care workflows.
North America: Market Leadership through Expanding Catheter Reduction Programs and Expanding Outpatient Surgical Recovery Programs
The North America bladder scanners market accounted for the largest regional share of 38.83% in 2025 due to increasing implementation of catheter reduction protocols across hospitals, rehabilitation centers, and long-term elderly care facilities in the US and Canada. The region is witnessing strong adoption of AI-enabled portable bladder scanners for postoperative urinary monitoring and emergency care workflows. Rising prevalence of neurogenic bladder disorders, expanding outpatient surgical recovery programs, and increasing investments in connected point-of-care ultrasound technologies are accelerating demand for advanced non-invasive bladder assessment systems across North America.
US Bladder Scanners Market
The bladder scanners market ecosystem in the US is influenced by increasing adoption of nurse-driven bladder scanning protocols aimed at reducing catheter-associated urinary tract infections in acute care hospitals. Rising utilization of handheld ultrasound systems in veteran healthcare facilities and skilled nursing centers is additionally supporting market demand. The market is further benefiting from growing integration of bladder scanners with electronic medical record platforms and increasing preference for rapid bedside urinary retention assessment during same-day surgeries, emergency medicine, and postoperative recovery management procedures throughout the US.
Canada Bladder Scanners Market
The bladder scanners market growth in Canada is driven by increasing utilization of portable bladder monitoring technologies across rural healthcare facilities and publicly funded elderly care institutions. Rising incidence of urinary dysfunction among aging populations and growing adoption of non-invasive bladder assessment in rehabilitation centers are strengthening product demand nationally. The market is also benefiting from expansion of
community healthcare programs and increasing clinical emphasis on minimizing unnecessary catheterization procedures in remote hospitals and long-term care environments across Canadian provinces.
The Asia Pacific bladder scanners market is expected to register the fastest growth with a CAGR of 8.05% during the forecast period, driven by rapid expansion of point-of-care ultrasound infrastructure across India, China, Japan, and Southeast Asian healthcare systems. Rising elderly populations with urinary incontinence and neurogenic bladder disorders are significantly increasing demand for non-invasive bladder monitoring technologies. Growing medical tourism, expansion of outpatient surgical centers, and increasing domestic manufacturing of portable ultrasound devices are improving affordability and accelerating hospital adoption of advanced handheld bladder scanners across Asia Pacific countries.
China Bladder Scanners Market
The Chinese market is expanding due to deployment of portable ultrasound technologies across Tier-2 and Tier-3 hospitals under national healthcare modernization programs. Increasing prevalence of diabetic bladder dysfunction and rising postoperative urinary monitoring requirements are supporting widespread adoption of bladder scanners in surgical and rehabilitation departments. Domestic medical device manufacturers are additionally strengthening market competitiveness with AI-assisted bladder volume measurement technologies.
Thailand Bladder Scanners Market
The bladder scanners market expansion in Thailand is led by rising adoption of non-invasive urinary monitoring technologies across medical tourism-focused hospitals in Bangkok and Phuket. Growing demand for postoperative bladder assessment following gender reassignment surgeries, urological reconstruction procedures, and elderly rehabilitation programs is increasing product utilization nationwide. Private healthcare providers are investing in wireless handheld ultrasound systems to improve bedside efficiency and minimize catheter-associated infections.
The bladder scanners market landscape is moderately consolidated, with major medical imaging and point-of-care ultrasound companies competing across portable, handheld, and AI-enabled bladder volume assessment segments. Established players such as Verathon, BD, and Laborie dominate the market through strong diagnostic portfolios, advanced ultrasound technologies, and extensive hospital distribution networks. The bladder scanners market competition is driven by innovation in AI-assisted imaging, wireless portability, automated bladder volume measurement, and non-invasive urinary monitoring technologies. Emerging companies are focusing on compact handheld scanners, cloud-connected monitoring platforms, and cost-efficient point-of-care imaging solutions to strengthen competitive positioning globally.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Analyst
Jay Mehta is a Research Analyst with over 4 years of experience in the Medical Devices industry. His expertise spans market sizing, technology assessment, and competitive analysis. Jay’s research supports manufacturers, investors, and healthcare providers in understanding device innovations, regulatory landscapes, and emerging market opportunities worldwide.
We are featured on:
sales@straitsresearch.com